ASHP® Injectable Drug Information™

A Comprehensive Guide to Compatibility and Stability

Edition:
2025
DOI:
https://doi.org/10.37573/9781585287444
Online ISBN:
9781585287444
Print ISBN:
9781585287437
Free access

List Price: $473.00

Member Price: $359.00

Page Count: 1800

The 2025 Edition of the industry’s go-to guide is newly updated with the latest information, ASHP’s Standardize 4 Safety (S4S) concentration standards including new Adult and Pediatric PCA and Epidural standard concentrations, the full list of the AHFS® Pharmacologic-Therapeutic Classification© system, 25 new monographs, and more than 270 new references for a total of over 25,000 total compatibility pairs.
 

Backed by quality, peer-reviewed published literature, ASHP® Injectable Drug Information™ has been one of pharmacy’s most trusted resources for more than four decades. 

Authored under the editorial authority of AHFS Drug Information® and published by ASHP, it is the global gold standard for IV compatibility and stability information.

The 2025 Edition of the industry’s go-to guide is newly updated with the latest information, ASHP’s Standardize 4 Safety (S4S) concentration standards including new Adult and Pediatric PCA and Epidural standard concentrations, the full list of the AHFS® Pharmacologic-Therapeutic Classification© system, 25 new monographs, and more than 270 new references for a total of over 25,000 total compatibility pairs.

ASHP® Injectable Drug Information™ 2025 features more than 420 monographs, including:

  • Sulbactam Sodium and Durlobactam Sodium
  • Rezafungin Acetate
  • Ublituximab
  • Mosnetuzumab
  • Teplizumab
  • Terlipresssin Acetate
  • Tecovirimat

Published under the editorial authority of ASHP®

American Society of Health-System Pharmacists®

Senior Vice President, Professional Development and Publishing Office: Daniel J. Cobaugh, PharmD, DABAT, FAACT
AHFS Editor in Chief and Senior Editorial Director: Michael Gabay, PharmD, JD, BCPS, FCCP
Editorial Director, Injectable Drug Information: Natalie C. Rosanelli, PharmD
Editorial Coordinator: Alexandra Rallo, BA
Director, Production and Platform Services: Johnna M. Hershey, BA